KNACK PHARMACEUTICALS
Live / Registered — Registered (as of 26 Oct 2021)
What this means for you
Registered since 26 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87817010
- Registration number
- 6540123
- Mark type
- Stylized text
- Filed
- 01 Mar 2018
- Published for opposition
- 17 Jul 2018
- Registered
- 26 Oct 2021
- Attorney of record
- Tomas Maria Casalins
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of epilepsy disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of Alzheimer; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for the treatment of bone disorders and bone diseases; Pharmaceutical preparations for the treatment of toxic effects; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for the prevention and treatment of hormone disorders and deficiencies; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for for the prevention and treatment of nausea and vomiting; Pharmaceutical preparations for the prevention and treatment of aids-related disorders and diseases; Pharmaceutical preparations for for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations, namely, injectable contraceptives
Owner
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
- KNACK PHARMACEUTICALS, INC., New York City, NY, US
Prosecution history
- 17 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Nov 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 18 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Sept 2021 — USE AMENDMENT FILED
- 10 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
- 17 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2021 — SOU EXTENSION 5 GRANTED
- 02 Mar 2021 — SOU EXTENSION 5 FILED
- 16 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Mar 2021 — SOU TEAS EXTENSION RECEIVED